
Keywords: L-PGDS; lipocalin-type prostaglandin D synthase; API; active pharmaceutical ingredient; BCS; biopharmaceutical classification system; SEM; scanning electron microscope; SE-HPLC; size exclusion high-performance liquid chromatography; CD; circular dichroism